<SEC-DOCUMENT>0001628280-23-017984.txt : 20230515
<SEC-HEADER>0001628280-23-017984.hdr.sgml : 20230515
<ACCEPTANCE-DATETIME>20230515061722
ACCESSION NUMBER:		0001628280-23-017984
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230515
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230515
DATE AS OF CHANGE:		20230515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCKWELL MEDICAL, INC.
		CENTRAL INDEX KEY:			0001041024
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				383317208
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23661
		FILM NUMBER:		23918209

	BUSINESS ADDRESS:	
		STREET 1:		30142 WIXOM ROAD
		CITY:			WIXOM
		STATE:			MI
		ZIP:			48393
		BUSINESS PHONE:		8004493353

	MAIL ADDRESS:	
		STREET 1:		30142 WIXOM ROAD
		CITY:			WIXOM
		STATE:			MI
		ZIP:			48393

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROCKWELL MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20120530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROCKWELL MEDICAL, INC.
		DATE OF NAME CHANGE:	20120525

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROCKWELL MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19970722
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>rmti-20230515.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:e9325c83-e945-41dc-a731-0d8a7980abd8,g:9737f56e-b5a6-4fc8-8b87-a9fa2ec45ed2,d:4a1a2a25ce4c4bc5a27b01b14ab7de36--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rmti-20230515</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl80L2ZyYWc6NjY4ZDRjNGE3YjJhNDI2ZjgyNjg4ZTRhMjY2YjJkOTQvdGFibGU6ODAyYTUxZjMwOTU4NDgxMTlkZDdjZGM5NDAyZWVhNmQvdGFibGVyYW5nZTo4MDJhNTFmMzA5NTg0ODExOWRkN2NkYzk0MDJlZWE2ZF8xLTEtMS0xLTY4MzUw_35daf6e0-c102-4b67-8387-d906dc00f227">0001041024</ix:nonNumeric><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl80L2ZyYWc6NjY4ZDRjNGE3YjJhNDI2ZjgyNjg4ZTRhMjY2YjJkOTQvdGFibGU6ODAyYTUxZjMwOTU4NDgxMTlkZDdjZGM5NDAyZWVhNmQvdGFibGVyYW5nZTo4MDJhNTFmMzA5NTg0ODExOWRkN2NkYzk0MDJlZWE2ZF8yLTEtMS0xLTY4MzUw_18c07cb1-bed7-4b0a-b5d1-fabc405474f9">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rmti-20230515.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001041024</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4a1a2a25ce4c4bc5a27b01b14ab7de36_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTA4_a7c01de6-922c-44a6-8d03-5596d6f5a052">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">the Securities Exchange Act of 1934</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;<ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yMzU_2c4cffcd-fff4-4719-bd41-0492168397a1">May 15, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTA5_c1d933a4-e59d-4649-9afd-8e0380aec871">ROCKWELL MEDICAL,&#160;INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.064%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.892%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6NTM4OWQzZDIxNTBmNGJmOGEwMDNmMjc4OTA5NmQ0ODAvdGFibGVyYW5nZTo1Mzg5ZDNkMjE1MGY0YmY4YTAwM2YyNzg5MDk2ZDQ4MF8wLTAtMS0xLTY4MzUw_a7d2be3b-059f-4e8d-a68c-f9e2cb0b1fae">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6NTM4OWQzZDIxNTBmNGJmOGEwMDNmMjc4OTA5NmQ0ODAvdGFibGVyYW5nZTo1Mzg5ZDNkMjE1MGY0YmY4YTAwM2YyNzg5MDk2ZDQ4MF8wLTEtMS0xLTY4MzUw_78181e96-1488-4e5e-843e-c33fe27dc26b">000-23661</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6NTM4OWQzZDIxNTBmNGJmOGEwMDNmMjc4OTA5NmQ0ODAvdGFibGVyYW5nZTo1Mzg5ZDNkMjE1MGY0YmY4YTAwM2YyNzg5MDk2ZDQ4MF8wLTItMS0xLTY4MzUw_c05a25a1-5a63-4574-81b2-0f67b27e9539">38-3317208</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTA2_f417b91c-3090-43ab-b108-aa2fba3ba6df">30142 S. Wixom Road</ix:nonNumeric>, <ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTAw_cbb8752a-be34-47f4-9945-34ecb1695af3">Wixom</ix:nonNumeric>, <ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTEw_eea0218a-8f1a-4635-aa49-3a8469e2057c">Michigan</ix:nonNumeric> <ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTAx_38ad566e-876a-4a19-a415-811e40b19bda">48393</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTAy_f243c9c2-7600-4549-b8cf-2a5aa97c0798">248</ix:nonNumeric>) <ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTAz_68762b9f-276b-48db-bb3d-1b1d4c1dc157">960-9009</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:454.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:427.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6ZTA0MmViYzMzMjdhNDk0YWFlNDA2Y2ZkMjNkOTBiMGIvdGFibGVyYW5nZTplMDQyZWJjMzMyN2E0OTRhYWU0MDZjZmQyM2Q5MGIwYl8wLTEtMS0xLTY4MzUw_7af22523-5be1-470d-8396-0f6b338e18c8">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:454.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:427.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6ZjVhZGZmMDc1ZjNkNDVmOTkyZTgyYjVhNDg1OTdhNzQvdGFibGVyYW5nZTpmNWFkZmYwNzVmM2Q0NWY5OTJlODJiNWE0ODU5N2E3NF8wLTEtMS0xLTY4MzUw_4bcdc109-5717-4b24-af52-b51fb3636af4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6MDgyNzJmMmUxYjg4NGIzNWE2NDI2YmUyZThhYjU5NGMvdGFibGVyYW5nZTowODI3MmYyZTFiODg0YjM1YTY0MjZiZTJlOGFiNTk0Y18wLTEtMS0xLTY4MzUw_f227213a-d145-423f-a530-ea308e7bd932">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:13.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6ZDA1YzUyYjY0MmFkNDFjMDk4NjY5MzdiZjBiNTU3ODQvdGFibGVyYW5nZTpkMDVjNTJiNjQyYWQ0MWMwOTg2NjkzN2JmMGI1NTc4NF8wLTEtMS0xLTY4MzUw_256daf24-0012-42d5-945f-27a760a273b3">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:33.504%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title&#160;of&#160;Each&#160;Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading&#160;Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name&#160;of&#160;Each&#160;exchange&#160;on&#160;which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6MTZkYmM3NzY2MmE2NDE5Njk2ZDBmMzc4ZDljYjAzOWEvdGFibGVyYW5nZToxNmRiYzc3NjYyYTY0MTk2OTZkMGYzNzhkOWNiMDM5YV8xLTAtMS0xLTY4MzUw_b479408e-b4f7-4be7-9c73-dd3eee8e8346">Common Stock, par value $0.0001</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6MTZkYmM3NzY2MmE2NDE5Njk2ZDBmMzc4ZDljYjAzOWEvdGFibGVyYW5nZToxNmRiYzc3NjYyYTY0MTk2OTZkMGYzNzhkOWNiMDM5YV8xLTItMS0xLTY4MzUw_66f21cea-3a78-45d0-8102-8f2dd88daadf">RMTI</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6MTZkYmM3NzY2MmE2NDE5Njk2ZDBmMzc4ZDljYjAzOWEvdGFibGVyYW5nZToxNmRiYzc3NjYyYTY0MTk2OTZkMGYzNzhkOWNiMDM5YV8xLTQtMS0xLTY4MzUwL3RleHRyZWdpb246MjBkMzhiNjA0MDQyNGRiNGE1ZTQ5ZmQzMGIwYWExNDhfNA_321a4cac-01e9-4e6d-8854-ee2554b18c22">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTA0_e687d4be-178a-47cc-9b39-51ce8e9d3d47">&#9744;</ix:nonNumeric> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Item&#160;2.02</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 15, 2023, Rockwell Medical, Inc. issued a press release and earnings presentation announcing its financial results for the quarter ended March 31, 2023. The press release and earnings presentation are furnished as Exhibit 99.1 to this Current Report on Form 8&#8209;K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated in this Form 8-K shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Item&#160;9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;text-decoration:underline">Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Exhibits&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The following exhibit is being furnished herewith:</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT&#160;INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:8.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="rmtiq12023earningspr-final.htm">Press Release, dated May 15, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ROCKWELL MEDICAL,&#160;INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 15, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;Mark Strobeck</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Strobeck</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>rmtiq12023earningspr-final.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i2aa18026fe1e4217957a6f8dd165a729_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 99.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:115%">Rockwell Medical Announces First Quarter 2023 Results </font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%;padding-left:13.8pt">Achieved fourth consecutive quarter of revenue growth with new high of $19.7 million, representing a 22.4% increase over the same period in 2022</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%;padding-left:13.8pt">Achieved $2.6 million in gross profit, representing a 425% increase over the same period in 2022</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%;padding-left:13.8pt">Continued to reduce expenses and improve earnings per share with focus on driving enhanced business performance</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%;padding-left:13.8pt">Entered into several new long-term supply, product purchase, and distribution agreements</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%;padding-left:13.8pt">Reiterates 2023 guidance of revenue between $78.0 million and $82.0 million and gross profit between $7.0 million and $9.0 million</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Wixom, Michigan, May 15, 2023</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> &#8211; Rockwell Medical, Inc. (the &#34;Company&#34;) (Nasdaq&#58; RMTI), </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, today announced financial and operational results for the three months ended March 31, 2023. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#34;Last year, we presented a new strategy and business plan for Rockwell that focused on enhancing our revenue-generating businesses, pausing our capital-intensive businesses, improving our financial condition, de-levering the Company, and driving us to profitability in 2024,&#34; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">said </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Mark </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Strobeck, Ph.D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, Rockwell Medical&#8217;s President and CEO. &#34;Our results for the first quarter of 2023, and the announcements we've subsequently made in the second quarter, continue to demonstrate that we are making significant progress towards these goals and objectives. We are putting Rockwell in a better position to drive growth and further improve our performance so that we can benefit more patients around the world.&#34; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">First Quarter 2023 Financial Highlights</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">Revenue for the three months ended March 31, 2023 was $19.7 million, which represents a 22.4% increase over $16.1 million for the same period in 2022 and an increase over the fourth quarter of 2022. </font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">Gross profit for the three months ended March 31, 2023 was $2.6 million, a 425% increase year-over-year compared with gross loss of $0.8 million for the same period in 2022. </font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">Rockwell continued to reduce its operating expenses over the first quarter 2023 by focusing on enhanced business performance and more efficient manufacturing processes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">For the three months ended March 31, 2023, operating loss was $1.4 million compared to $6.6 million for the same period in 2022 and an improvement over the fourth quarter of 2022. </font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">For the three months ended March 31, 2023, Rockwell's net loss was $1.75 million, or $0.10* per share, compared with a net loss of $7.2 million, or $0.84 per share for the same period in 2022 and an improvement over the fourth quarter of 2022.</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">Cash and cash equivalents at March 31, 2023 was $16.8 million compared to cash and cash equivalents of $21.5 million at December 31, 2022. The variance was largely driven by fees associated with the reacquisition of Rockwell's distribution rights from Baxter, one-time severance payments, and fees associated with terminating a supply agreement.   </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 99.1</font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Financial Highlights</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.538%"><tr><td style="width:1.0%"></td><td style="width:55.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.912%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Three Months Ended March 31</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:125%">(In Thousands, Except Per Share Amounts)</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2023</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2022</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Net Sales</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">19,668&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16,124&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Gross Profit (Loss)</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,599&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(786)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Operating Loss</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,427)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(6,626)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Net Loss</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,750)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(7,162)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Basic and Diluted Net Loss per Share</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$      (0.10)*</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.84)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:115%">* </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Basic and Diluted Net Loss per Share includes 5,911,000 of shares of common stock issuable upon the exercise of the pre-funded warrants in the weighted average shares of common stock outstanding for the three months ended March 31, 2023. For more details, see Note 3 on Form 10-Q filed May 15, 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">First Quarter 2023 Operating Highlights</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#212121;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">Effective January 1, 2023, Rockwell assumed 100% commercial responsibility for Baxter's customers which were previously serviced under the exclusive distribution agreement that was terminated subsequent to the acquisition of this business in the fourth quarter of 2022. Rockwell is actively working with customers to establish long-term supply agreements with optimal pricing and contractual minimums. The majority of Baxter customers have transitioned successfully over to the Rockwell platform and are actively buying products. Rockwell has already begun to experience the benefits of these changes and expects to realize the full impact of these actions during the second quarter of 2023 and beyond.</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">In February 2023, we announced two long-term, multi-million-dollar supply and product purchase agreements that strengthen our revenue base over the next several years and grow our hemodialysis concentrates business. The first arrangement is with the largest non-profit dialysis provider in the United States. The second is with Concerto Renal Services, the largest provider of dialysis in skilled nursing facilities in the United States. </font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">Additionally, during the first quarter of 2023, Rockwell established new non-exclusive distribution services agreements with Cardinal Health and Medline Industries for distribution of Rockwell's hemodialysis concentrates products throughout the United States. </font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:13.8pt">Rockwell continues to evaluate potential business development opportunities to strengthen the Company's existing hemodialysis concentrates business and potentially expand into new product categories and markets.</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;padding-left:14.15pt">Rockwell was certified as a Great Place to Work in the United States. Great Place to Work</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:115%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%"> is the global authority on workplace culture, employee experience, and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation.</font></div><div><font><br></font></div><div><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">CONFERENCE CALL AND WEBCAST DETAILS</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 99.1</font></div></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:200%">Date&#58;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:200%"> Monday, May 15, 2023</font></div><div style="padding-left:18pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:200%">Time&#58;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:200%"> 8&#58;00am ET</font></div><div style="padding-left:18pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:200%">Webcast&#58; </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:200%">www.RockwellMed.com&#47;Results</font></div><div style="padding-left:18pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:200%">Live Number&#58;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:200%"> (888) 660-6347 &#47;&#47; (International) 1 (929) 201-6594</font></div><div style="padding-left:18pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Replay Number&#58;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> (800) 770-2030 &#47;&#47; (International) 1 (647) 362-9199</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">  A replay will be available via the replay number and webcast through June 14, 2023. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Access Code&#58;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> 4944610</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Speakers&#58;</font></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Mark Strobeck, Ph.D. &#8212; President and Chief Executive Officer&#59; and </font></div><div style="margin-top:3pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%;padding-left:13.8pt">Paul McGarry, CPA &#8212; SVP, Finance and Chief Accounting Officer.</font></div><div><font><br></font></div><div style="padding-left:18pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Format&#58;</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> Discussion of first quarter 2023 operational and financial results followed by Q&#38;A.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">About Rockwell Medical</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Rockwell Medical, Inc. (Nasdaq&#58; RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient&#8217;s home. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Rockwell Medical is the second largest supplier of acid and bicarbonate concentrates for dialysis patients in the United States and has the vision of becoming the leading global supplier of hemodialysis concentrates. Certified as a Great Place to Work</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> in 2023, </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Rockwell Medical is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Driven to Deliver Life-Sustaining Dialysis Solutions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">For more information, visit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">www.RockwellMed.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Certain statements in this press release may constitute &#34;forward-looking statements&#34; within the meaning of the federal securities laws. Words such as, &#34;may,&#34; &#34;might,&#34; &#34;will,&#34; &#34;should,&#34; &#34;believe,&#34; &#34;expect,&#34; &#34;anticipate,&#34; &#34;estimate,&#34; &#34;continue,&#34; &#34;could,&#34; &#34;can,&#34; &#34;would,&#34; &#34;develop,&#34; &#34;plan,&#34; &#34;potential,&#34; &#34;predict,&#34; &#34;forecast,&#34; &#34;project,&#34; &#34;intend,&#34; &#34;look forward to,&#34; &#34;remain confident,&#34; &#8220;guidance,&#8221; or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward looking statements. There can be no assurance that&#58; Rockwell Medical will grow its hemodialysis concentrates business and further improve its performance&#59; Rockwell Medical will be able to enhance the economics in its current customer agreements&#59; Rockwell Medical will add new long-term supply agreements with new customers and will transition Baxter customers&#59; Rockwell Medical will achieve its projected total revenue and gross profit for 2023&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Rockwell Medical</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> will be able to achieve planned cost savings to operate its concentrates business profitability or achieve the other components of its strategy&#59; Rockwell Medical will achieve profitability in 2024&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> Rockwell Medical will expand </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 99.1</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">into new product categories and markets&#59; Rockwell Medical will be successful in evaluating potential business development opportunities&#59; that Rockwell Medical will realize benefits from the Baxter transition&#59; or Rockwell Medical&#8217;s future cash balance will be sufficient to fund operations going forward</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. While Rockwell Medical believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in Rockwell Medical's SEC filings), many of which are beyond our control and subject to change. Actual results could be materially different. Risks and uncertainties include but are not limited to those risks more fully discussed in the &#34;Risk Factors&#34; section of our Annual Report on Form 10-K for the year ended December 31, 2022, as such description may be amended or updated in any subsequent reports filed with the SEC. Rockwell Medical expressly disclaims any obligation to update our forward-looking statements, except as may be required by law.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"># # #</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CONTACT&#58; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Heather R. Hunter </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">SVP, Chief Corporate Affairs Officer</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(248) 432-1362</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">IR&#64;RockwellMed.com</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Financial Tables Follow</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%">###</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 99.1</font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.448%"><tr><td style="width:1.0%"></td><td style="width:60.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.233%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">ROCKWELL MEDICAL, INC. AND SUBSIDIARIES</font></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(Dollars In Thousands)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">March 31,</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">December 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2023</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">2022</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">(Unaudited)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and Cash Equivalents</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16,834&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">21,492&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total Assets</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">40,472&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">46,635&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total Liabilities</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">27,930&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">32,529&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total Stockholders&#8217; Equity </font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,542&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">14,106&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common Stock Outstanding</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,552,673&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,163,673&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common stock and common stock equivalents*</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">31,343,670&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">31,356,373&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">*Common stock and common stock equivalents&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common stock</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,552,673&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,163,673&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common stock warrants (pre-funded)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,911,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,300,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common stock and pre-funded stock warrants</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">18,463,673&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">18,463,673&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Preferred stock converted</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,363,636&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,363,636&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Options to purchase common stock</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,194,202&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,206,905&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Restricted stock awards</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">891&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">891&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Restricted stock units</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">125,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">125,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common stock warrants</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,196,268&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,196,268&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total common stock and common stock equivalents</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">31,343,670&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">31,356,373&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:239px"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Exhibit 99.1</font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.115%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.569%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">ROCKWELL MEDICAL, INC. AND SUBSIDIARIES</font></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS</font></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(In Thousands, Except Shares and Per Share Amounts)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three Months Ended March 31,&#160;2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three Months Ended March 31,&#160;2022</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Net Sales</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">19,668&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16,124&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cost of Sales</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">17,069&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16,910&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gross Profit (Loss)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,599&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(786)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Research and Product Development</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">278&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,567&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Selling and Marketing</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">498&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">455&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">General and Administrative</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,250&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,818&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Operating Loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,427)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(6,626)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Other (Expense) Income </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Realized Gain on Investments</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest Expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(387)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(540)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest Income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">64&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Total Other Expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(323)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(536)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Net Loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,750)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(7,162)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Basic and Diluted Net Loss per Share</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.10)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.84)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Basic and Diluted Weighted Average Shares Outstanding</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">18,359,940&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,544,225&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rmti-20230515.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:e9325c83-e945-41dc-a731-0d8a7980abd8,g:9737f56e-b5a6-4fc8-8b87-a9fa2ec45ed2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rmti="http://rockwellmed.com/20230515" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://rockwellmed.com/20230515">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmti-20230515_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rmti-20230515_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://rockwellmed.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rmti-20230515_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:e9325c83-e945-41dc-a731-0d8a7980abd8,g:9737f56e-b5a6-4fc8-8b87-a9fa2ec45ed2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_7ca94f31-bee3-4555-906e-8e226ea3a10f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3cd04f76-7394-4f8c-a0b1-a2144d6a9f59_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_40b23797-bf3e-4ae3-8df6-47fe5a2c5ea6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f18cf8a7-9d2a-4fdc-a1b7-b7cbf790af99_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8d9f3827-8f63-47e5-be60-89726590b66d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_373ab22b-1211-45cb-a6e5-c1236c1df345_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_d5b382cd-cb87-4a0b-b7bc-faf9b3a0474c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_bf88bea6-21e4-459b-a43d-c45e6b665205_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_187dd8b1-5133-4685-863f-6d0fee21e02c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_85e5d9e3-777e-4f3d-a9f4-5c25a6d9acf4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_162e285b-167e-442d-9eb8-e38cdf06a4c8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_b8419b39-c7c4-4ca9-85f8-b9f488fb5394_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4ebe27a2-19e3-4337-8de7-a3627806faa9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_43d6c5bd-8ea9-4537-88c5-f1dd73d8d7f0_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_eb23f75b-2cc4-45de-ac62-f288b0b57289_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c93aaff9-0a83-49f5-aa1f-8452464af246_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b19176e9-d5d0-4ea9-ab79-f5478536b30b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e1e1c9f2-1b18-4940-8310-4870daf79504_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_442bd4f7-7f02-4538-bb6f-7b81d9a9490d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d5b64014-f990-48d7-9b60-29e998814f16_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fe6d0b75-3ad3-4180-94b0-1901401d566f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4a1229a8-648a-4456-9b6f-bcbf2e7c8c6a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_6ae176a9-4caa-4747-b808-f09c65d053fa_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rmti-20230515_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:e9325c83-e945-41dc-a731-0d8a7980abd8,g:9737f56e-b5a6-4fc8-8b87-a9fa2ec45ed2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://rockwellmed.com/role/Cover" xlink:type="simple" xlink:href="rmti-20230515.xsd#Cover"/>
  <link:presentationLink xlink:role="http://rockwellmed.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f9b29893-6fe9-441a-b86b-05131da0153d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_DocumentType_f9b29893-6fe9-441a-b86b-05131da0153d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_fc89fac8-daca-4788-a369-23738980018e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_DocumentPeriodEndDate_fc89fac8-daca-4788-a369-23738980018e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8e2f30dc-de18-45ca-99d5-84b817312b97" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityRegistrantName_8e2f30dc-de18-45ca-99d5-84b817312b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_38b8f085-b5d1-45c6-a558-f0266176bfc0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityIncorporationStateCountryCode_38b8f085-b5d1-45c6-a558-f0266176bfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d2c7334e-1ed7-4f1a-9eaa-a3b4d1573684" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityFileNumber_d2c7334e-1ed7-4f1a-9eaa-a3b4d1573684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_48414abb-1ce7-4470-a8fa-9a8621994c30" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityTaxIdentificationNumber_48414abb-1ce7-4470-a8fa-9a8621994c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ed3a250e-7e16-4859-a433-0e6ab2c0fdd8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityAddressAddressLine1_ed3a250e-7e16-4859-a433-0e6ab2c0fdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ab818f73-66f1-43a0-85b8-88983009e220" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityAddressCityOrTown_ab818f73-66f1-43a0-85b8-88983009e220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c479bafa-db5d-4920-b586-5d385a558fe9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityAddressStateOrProvince_c479bafa-db5d-4920-b586-5d385a558fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6c741153-5470-447e-b579-0f11511efe1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityAddressPostalZipCode_6c741153-5470-447e-b579-0f11511efe1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a68a89e2-b144-4d06-9bce-9a9f5ab08b9d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_CityAreaCode_a68a89e2-b144-4d06-9bce-9a9f5ab08b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_cb18caba-a1c6-475e-9600-7016a2b85eb1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_LocalPhoneNumber_cb18caba-a1c6-475e-9600-7016a2b85eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_95201fc3-1f41-4f27-a32a-bb8ec70d69d4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_WrittenCommunications_95201fc3-1f41-4f27-a32a-bb8ec70d69d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_7c20f1c8-ef74-41e1-9878-c0673c3a8d38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_SolicitingMaterial_7c20f1c8-ef74-41e1-9878-c0673c3a8d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_27d7cb6f-81c0-4942-9706-d179dd4d6e77" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_PreCommencementTenderOffer_27d7cb6f-81c0-4942-9706-d179dd4d6e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_471db2bf-9c77-4acf-b2b9-d18438570af0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_471db2bf-9c77-4acf-b2b9-d18438570af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ae68e8aa-dce5-4fbb-bd84-8b02330924cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_Security12bTitle_ae68e8aa-dce5-4fbb-bd84-8b02330924cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7d1e0372-796b-4b3d-95ab-9bfdb6e5e385" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_TradingSymbol_7d1e0372-796b-4b3d-95ab-9bfdb6e5e385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a7a2134f-b62b-4d3e-8e45-2d15eef8cb83" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_SecurityExchangeName_a7a2134f-b62b-4d3e-8e45-2d15eef8cb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f5c929f9-d960-4963-8960-76bfd69e279e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityEmergingGrowthCompany_f5c929f9-d960-4963-8960-76bfd69e279e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0e3d1439-1fef-4f95-82a0-3040fd4f72ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_EntityCentralIndexKey_0e3d1439-1fef-4f95-82a0-3040fd4f72ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b1035ff8-d572-422d-a0da-52e94495a8fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_79ad7d0d-8cbf-43ed-893f-21332cb23a47" xlink:to="loc_dei_AmendmentFlag_b1035ff8-d572-422d-a0da-52e94495a8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_2a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_2a.jpg
MB5!.1PT*&@H    -24A$4@   B<   "(" (   "SY]R8     7-21T( KLX<
MZ0  RN))1$%4>%[M_5>4G5EVF F&]]Y[1"#@O<U$^JS**I81BT6RR"ZJ25&B
M*+.Z6^I^F(=^U?/TS,.L-:.6UHR:;,ZTBE2+GL5B^;1()+SW"(3WWON8;^]]
MSF]N1  1 !),DO?FGX%K?G/./OML;U+7UM92DJ\D!)(02$(@"8$D!%X*!-)>
MRE.2#TE"( F!) 22$$A"0""0Y#I)/$A"( F!) 22$'AY$$ARG9<'Z^23DA!(
M0B )@20$DEPGB0-)""0AD(1 $@(O#P))KO/R8)U\4A("20@D(9"$0)+K)'$@
M"8$D!)(02$+@Y4$@R75>'JR33TI"( F!) 22$$ARG20.)"&0A$ 2 DD(O#P(
M)+G.RX-U\DE)""0AD(1 $@))KI/$@20$DA!(0B )@9<'@237>7FP3CXI"8$D
M!)(02$(@R762.)"$0!("20@D(?#R()#D.B\/ULDG)2&0A$ 2 DD()+E.$@>2
M$$A"( F!) 1>'@227.?EP3KYI"0$DA!(0B )@=27W%_'FOFD/B_@@YY V[J3
M>WAD#-'>0MNZU?-.('E]$@))"$0@\(((PQ<(IG__9O3"@/LRN,Y:BBQ JOZS
MEBK$G:?J/S:-*+F7,]?T&_=ME$7H^U1NQ"GN>\[REV_ 0:(+KU?IS?W]W3?^
M6?Y6SX8M3[Y*?W5PV&#63U_.IPUJ'2?=)@^-04H;_:7J2OW]?IG(M=V96A_$
MC<"S\2H]^2F;_;K^^^AS-\.'C<:6>&[TSL\& <.*S>&P7:P)=F)D.]N.2:0/
MV[WSLY^_*82-FD6HEA?<E6J%9"NX@7SEX1R%V_;VU_.LU+-#X?.Y\O.SL(4T
M/<2?Q#G8.5%VL?$L(R=Y?A.>N/[RK=YVW<.>/I+G6(7/]>;/,:ZM7KJ5E0H@
MG_!FJ\]XN>?]75P12+T<VP?4,URRV4/6K_+VA_/WYHKMP74KF^CO#6@VG<CG
MI.NP,5:%\Z_!U6(L774<^\HM@&H>3D2(27-.#K7S3/M9,X4ID"G<)Z<XJ4QA
MFE!X"A?9)WNB#LHABOLGHEC9L!*^V#82;"25R+/T><^DZ3AP!0PZ M+M"4Q/
MF$NB;!>?10C5</7"V=AMY9S$N[@')LBPVP;I4R\(\")A4)M]'Y%UO'1JRQ.!
M9Y2>K ?S5F3/#<Y93Z36W7I3[2<FHC'23==^W1V"-O4A;F]W_!%I/;Y_'-BB
M$OW& UN'4=&U<@J#Z9T;:%&;(-93$>/S/<$) 'XIXJ0NH#M^#,$<C0K)E)ZL
M9V_EG&U/\ L R9? =6)@\5S'UB>@Q;:!'#^PG1]@^<K:VN)*RM+*VM+*"G^7
M5U/X9@6VMK:VNB:\#5:3QNJEIJ9SI*5DR)&:E<Z1EIF6QD]I(=%3D.L@G+W+
M/=D&&1W/LY/SS;E.>,_MW]U&;N-,X#I;H&1/Q\UGX#H)#/H)7,?&O/U)/WW8
M[HQM<IUU3'0C2K<YUU$\<5SJ29-Z(M?QMU\GY&Q":^R! 08\"9X;6.<BPI?;
M>]ND>I\SUW'[W8N7NDNCD%F'GAXU/D>D>AKVF<_ =N039(#P-AO9-J,/29Q+
MDNL\;0EBOP<R@&Z4*,:$>S5D/*$!-Z(*!>1D865U8F%E?&YY9'9I<F%E=FE5
MCN7EA96UE15!5FZ4GI::D9Z>DY&6GYE6D)56D)E6DI-1D9]1F)V>G9$.$S)=
MQQ0?KUU%AA6^C4HOVT;HS6WT";SB!5+@D-9'5F!KFR!R06R)UM&C",5QNF-<
MIPP M9[_!=+#Y\MUMH&=CET$\L<6Z86C+2H.F92:R$JW0R,25LU!-2KYQNX6
MZ"K!/+?K==M$,GG:F#<4C-=;^+8$PZ>MD6V]!%S:$&V4V"=2DJ?=_HF_;X2X
MX05Q.3B069T8H(BPP3B?!MM AHCJ>=NF.5N9MI]=.,L7LF!;>?2&YWQ.NHXA
MA?&0)W,= [U';L=U4&)2EE;7%I?7YI96Q^=7!F>6^J<7^Z86AF>683S32_">
ME475>S@5*QY<!]X"UX'E%&>EE^5D5.5GU!=F5A5DE>1E%F9GY&:F9::+C6X=
MUQ&4B6CT2:X3Y1.>]8=TUJV54Q<#4KR)'J/[R6CT%XWK&&J:COWT[1/#D.?E
M.H;M44Z2P'442QU5C=@"HV/=PIACLTHDJZ:G/EECBVS,!!BY&>@3Q*:]<7#%
MT\$:'Z)Q'<]Y H:W?JI_*UPG:A\S@N5@ZG'HV305E3]DL<5:LR5<W!BL&\H'
M?O_&_M5G;07IM[E^6S_]\^(Z(7D/6(IC1$J#=-H.3@$C<("094"_F5I8@\?T
M3BYV3RUV3RYP]$PN#,TL3\RMS"UC88/=R&*9KB.W2T7=2<W*2"W,2H/KU.1E
M[BC,;"K):2K/:RC)J2O*+,I.%\]00&MLT]G>L^T3\_YL=ULGPGP#*T>4=F]S
MU:,XM>[.+T"4B1&EB*X3>5:45L8D[<UL36Z;AFK!UM%R^V<F4M78_HT#:..5
MC3H /3V)#,/1:..@(;YLX(%XXM@C>I)'/+<APEC,Z#GN_H:=AJ0Q3ODD6A,G
MZ?J)V]E]W!3\/<T4D*CC!EPGLCF"<QQ,_3F;4,Q-Y?UU X\H4*9%>A-X,,8-
MYK,E.^=VD6GSG:NDRC'9!"S:$*F,-SU)LC&QS&^GD.ML04^*3BM8J8WO$+$V
M177$[0+FA9W_N7(=MU4"[N)$%.&S N<(UY$SEU?7YI979Q97IA>71F:7^Z>7
M^Z:6X#I]4XO],TN#,XO#,TO8V:875Y=64M21(_L_D-A0CWBEI:5D9Z059654
M9*779*<U%&4W5^<?K"TXW5!059 YO[3*4]AQV-S0?O  F9[#7K3E"GG2\S&=
M@. &[L( 82,8MHU5?"+7\?>)4MYMCG\+7,=VG!O(^LC1F!7>D;A$@KJ-"6_W
MU*=SG>",#65GTX/]IMWD;G&>891::7AXRZ>L00(U4:Q(O,,&7">\?Y3K1&F-
M,88-7Q':YQ[FG^I.=Q>NHZ>;<AV'U6[TB1/P@]B0DT5Q-?0+VA#U-V,YAD"1
MZ6PRN9@"\AR:0A1PFW =QQLB4'KR'O/04ZG8*$LPP>!Q"5)(./5U5NXG;H@M
M<9WU=L+M;K(7=?[GQG5BR^BA+40K$4>#I9M:7.F=6FH?G[\_//-@>.[AR *&
M-?@0K&*>O\L8W%8QNRVO$D$@D0)H-B@OJBNN$EP *]) @U78459:>M;J6L["
M<G%.>DUU_FL[B__QT<H=)3D]DXL8Z.!515GI]479A=EI/I=(,&.[IO+-UB#*
M<J*;++HIMLD4-EWNC63M#9#[Z>BRA8NBTFA\_(+TMJXQJA$E'"]JPIM#8OV6
MCIP;83F)M,SL&_8R*T?":V/01"$?H1WN5AX:[K8&FL3[;J8DKE.U(D-VMW'"
MEC-@*J5>IVWX42ES,-H7CB-F_8Y,.CK,C6B9+G3</B/WM_'8!+=&E\.;>TG<
MS2F 4GPM-D50XU@)/S^_!2FJY6^D=H4\-4"=8.2>B0:# L ; #..#U'OSCI<
M>=H7T6B:$.<VN,IA^_-9\YXVFJ?]_G*YCD</A_(IJ:NK:S 2])O1^>7>J<5'
MH_,/1^;O#<\^&IGO&%N865K)R4S+58>-_$U/S833:' :F@I_"5I+0]U)75M9
M35E825E8QC2G_IZ5U,7YY?G)>8QJU55YK[:4_,:1"A2@3]LGNL87F'-M4=:)
MQL+&TFSU]XC\Z-#T11#'J*P4$>)BE.>YGQ/L<*,X<82/4)>G(8#_/7%31\AT
M>$IXTE:Y3D"+GGO"3YS(D[=T]%?G9G)W<Z0C,J]$KK/IG2-<)Z 7(7?P[VS:
M$?D],HVM6U&BC#)"4Z+\\DE<1]E.('%'IAY:U9Z,)E'T2AA+P 4#0"78H#9;
M^$2NHQLPZNN*BH$;8&-TQ)K#%$/Z%\=U0A>.9]H1:$3&&XL$<8,+!N7BF/R8
MO02P$=MY-N%W$PQ9OZQ_K[E.+))5UR82".D1;BT5#69R?KEM;/Y\_]3-@9E'
M(PM]DXM3Q LLKLPNKF$KJRW,K"O*JB_,KBG(J,I-+\G-R,O.R,_.(&H 5N1B
MTU*(HA9=!\6("Z?F5R;FET>G%P?&9V%+317Y>ZOSC]3D]X[-_V^?]%QIGTQ9
M7N&;;YVJ/M52W%""QI,A9%O4_81Q;I5B*VD-^4L\YV =V=I4:'L:70U^UYRD
MB(3HMX'3RF/L;:MSB(PJ$A!J4JUW>43VDC<WZ%97VAW=]>OX[C:]6%L=='!>
M#,AQ:JZPBMS0:(?W;QBI>L*2/)F?!;Z01'ZCAELS)+O5V4@KC5/.37T&'N[A
M^@9+''FNOETO/,4SW)X 6;N5NZ'=+*H<^2L-( '$HJY2+TS:/G*WV(S"KB,)
M[I[!RK@+(WKDII)+3$UXMOUEDX],._*%F[J#1KC1X]E=F]G$#!CF2%.L6!_]
M&,.#+=O68GB^R:S7VX0W-/1M>\,]WP6?EZ[S5*ZSL"SQ @/32X]'YVX.S5[H
MF[HS/-<[ODC<&H:OPJR,PJSTRORLII+LAN(LK&&URG6*<S+R.+(R\C,E(T<U
M%"$:<!V,;,12HS;!M(3KS"P.3,W#EFJ+<BL*LDIS,RYW3/Y??_3XD[LC*7-+
M1^H+?NO=QG<.5+16Y!?E9BZB*Z6D9&.U2TM($]@J=%\BU]&:/J%-(;*KMXRO
M&\Q*;^D-)3$J;1".O/14$]\3=ZD[ZZ5SG9!<"D>)P8$/L=$;Z;+H>1ON.F(6
MW<'K&%8<=E$K5GP0_MY>>5I/T1+N9,1)QA/J6S%:$G^6)\K!76S6X90\M]MX
MCG9> JUR[,3/>7VD4\"9(A>J%A5WF<M]ML!U(E3;T,]-(#JJ;693!LNU*8?:
M /?C((Q9#B)T++:0SB45REN;QS4XF5LG&-LO&_+C;=C9-N$Z3\>9)X'@I?SV
M^7&==<./07QM>';Y[O#<Y=[IC]HG[@W/86&;6EB=6UPMS4D_4)6WKS)W=UDN
M$6CH.N@WV,'0;,3"1H0TJ3GZ-U!T;#'! QC/"LFD:K7#";2 H0U>DBGY.BS]
M)VWC_\O/VC^Y,YPR/GNT-O^WWVM^YV!E4V5!5F;ZZ.PR@065^9EY&E[]#*_-
M!*Q-!*-G>$*X-6Q_!M%( ?5PVV*SH3SEF4HI8N<H(-RJ1:P**NJNMS:LO_W6
M+4C/ X[(M1OL6-OR<4=$ *#X2KNO'>55[J5D,':6DIDX5XOH!^&IL1"LC7U%
MP6BCY#]*B:(C,6YDZQ&.WUF6O!G!.P\X03E!A!5LA-2Q6^F\#%;N'QU*]+J
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M:/CB\,N3E+@@&2*LWQCAW'1YV3Q(=6F9V>DM.ZI>?V7/COH*C=KQ6R E!9D
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M,=4]@B=FM::8(#HQ^$5B?:+($;[?$&7ZE>MT]H[@'5E<7%H'0Z=_1'F [N2
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M3QQNL4*B)J'R1VN1C6&(^S_^[!/B"&:F*4*ZK%7(5$>4EZF!1A+7<O.R*(A
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M[\<-6UM9*JJMSLYY <.)1I\F[UTT0?<0,I-&3L>XH45.$Z\?C9S>4$M+N&^
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M>&CX>A8"I$L4%P*><U(;7N[P,!I-\'D\YOGON66ND\@%G,P;R %8W:F9.TO
MR^HJ,6O%V6D4(X"LD^/@S.>$Y<"9YC#!+8XM+H_B!)I8'*$#_;)$(AG+<0^Q
M?U3>#/3<<.5CANVM0B JICLZO;9*[35J@U;FDP.>AOI"71Q*94.^O-U99 :,
M3!3U*2+Y7WRD%+%>GI8.;X[D^QVR[7T2TQK\7I1YN]@B#XJ0WKG-;Q-Q@3UF
MBPOU +>EU7M<1$[[MW_A).7("%/6S6[>H]2,]/3<O$QBQM6KS _F8W!N%>-
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MHC5LI'>GV? %4-F9$$TJC+&E:?=I!#R0?U0L,30)%S6Z)X$WS !AG-_I1T
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M*4EJ/2^/UB:?M $$! &):4+,QYF!;X9$4<@FEC127J[?Z80VH>Y,3,]V]8W
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A\DE)""0AD(1 $@+_?V=^N>D[9%*(     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139675582605984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 15,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ROCKWELL MEDICAL,&#160;INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-23661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-3317208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">30142 S. Wixom Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wixom<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">48393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">960-9009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RMTI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001041024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>rmti-20230515_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rmti-20230515.xsd" xlink:type="simple"/>
    <context id="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001041024</identifier>
        </entity>
        <period>
            <startDate>2023-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl80L2ZyYWc6NjY4ZDRjNGE3YjJhNDI2ZjgyNjg4ZTRhMjY2YjJkOTQvdGFibGU6ODAyYTUxZjMwOTU4NDgxMTlkZDdjZGM5NDAyZWVhNmQvdGFibGVyYW5nZTo4MDJhNTFmMzA5NTg0ODExOWRkN2NkYzk0MDJlZWE2ZF8xLTEtMS0xLTY4MzUw_35daf6e0-c102-4b67-8387-d906dc00f227">0001041024</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl80L2ZyYWc6NjY4ZDRjNGE3YjJhNDI2ZjgyNjg4ZTRhMjY2YjJkOTQvdGFibGU6ODAyYTUxZjMwOTU4NDgxMTlkZDdjZGM5NDAyZWVhNmQvdGFibGVyYW5nZTo4MDJhNTFmMzA5NTg0ODExOWRkN2NkYzk0MDJlZWE2ZF8yLTEtMS0xLTY4MzUw_18c07cb1-bed7-4b0a-b5d1-fabc405474f9">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTA4_a7c01de6-922c-44a6-8d03-5596d6f5a052">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yMzU_2c4cffcd-fff4-4719-bd41-0492168397a1">2023-05-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTA5_c1d933a4-e59d-4649-9afd-8e0380aec871">ROCKWELL MEDICAL,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6NTM4OWQzZDIxNTBmNGJmOGEwMDNmMjc4OTA5NmQ0ODAvdGFibGVyYW5nZTo1Mzg5ZDNkMjE1MGY0YmY4YTAwM2YyNzg5MDk2ZDQ4MF8wLTAtMS0xLTY4MzUw_a7d2be3b-059f-4e8d-a68c-f9e2cb0b1fae">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6NTM4OWQzZDIxNTBmNGJmOGEwMDNmMjc4OTA5NmQ0ODAvdGFibGVyYW5nZTo1Mzg5ZDNkMjE1MGY0YmY4YTAwM2YyNzg5MDk2ZDQ4MF8wLTEtMS0xLTY4MzUw_78181e96-1488-4e5e-843e-c33fe27dc26b">000-23661</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6NTM4OWQzZDIxNTBmNGJmOGEwMDNmMjc4OTA5NmQ0ODAvdGFibGVyYW5nZTo1Mzg5ZDNkMjE1MGY0YmY4YTAwM2YyNzg5MDk2ZDQ4MF8wLTItMS0xLTY4MzUw_c05a25a1-5a63-4574-81b2-0f67b27e9539">38-3317208</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTA2_f417b91c-3090-43ab-b108-aa2fba3ba6df">30142 S. Wixom Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTAw_cbb8752a-be34-47f4-9945-34ecb1695af3">Wixom</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTEw_eea0218a-8f1a-4635-aa49-3a8469e2057c">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTAx_38ad566e-876a-4a19-a415-811e40b19bda">48393</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTAy_f243c9c2-7600-4549-b8cf-2a5aa97c0798">248</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTAz_68762b9f-276b-48db-bb3d-1b1d4c1dc157">960-9009</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6ZTA0MmViYzMzMjdhNDk0YWFlNDA2Y2ZkMjNkOTBiMGIvdGFibGVyYW5nZTplMDQyZWJjMzMyN2E0OTRhYWU0MDZjZmQyM2Q5MGIwYl8wLTEtMS0xLTY4MzUw_7af22523-5be1-470d-8396-0f6b338e18c8">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6ZjVhZGZmMDc1ZjNkNDVmOTkyZTgyYjVhNDg1OTdhNzQvdGFibGVyYW5nZTpmNWFkZmYwNzVmM2Q0NWY5OTJlODJiNWE0ODU5N2E3NF8wLTEtMS0xLTY4MzUw_4bcdc109-5717-4b24-af52-b51fb3636af4">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6MDgyNzJmMmUxYjg4NGIzNWE2NDI2YmUyZThhYjU5NGMvdGFibGVyYW5nZTowODI3MmYyZTFiODg0YjM1YTY0MjZiZTJlOGFiNTk0Y18wLTEtMS0xLTY4MzUw_f227213a-d145-423f-a530-ea308e7bd932">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6ZDA1YzUyYjY0MmFkNDFjMDk4NjY5MzdiZjBiNTU3ODQvdGFibGVyYW5nZTpkMDVjNTJiNjQyYWQ0MWMwOTg2NjkzN2JmMGI1NTc4NF8wLTEtMS0xLTY4MzUw_256daf24-0012-42d5-945f-27a760a273b3">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6MTZkYmM3NzY2MmE2NDE5Njk2ZDBmMzc4ZDljYjAzOWEvdGFibGVyYW5nZToxNmRiYzc3NjYyYTY0MTk2OTZkMGYzNzhkOWNiMDM5YV8xLTAtMS0xLTY4MzUw_b479408e-b4f7-4be7-9c73-dd3eee8e8346">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6MTZkYmM3NzY2MmE2NDE5Njk2ZDBmMzc4ZDljYjAzOWEvdGFibGVyYW5nZToxNmRiYzc3NjYyYTY0MTk2OTZkMGYzNzhkOWNiMDM5YV8xLTItMS0xLTY4MzUw_66f21cea-3a78-45d0-8102-8f2dd88daadf">RMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGFibGU6MTZkYmM3NzY2MmE2NDE5Njk2ZDBmMzc4ZDljYjAzOWEvdGFibGVyYW5nZToxNmRiYzc3NjYyYTY0MTk2OTZkMGYzNzhkOWNiMDM5YV8xLTQtMS0xLTY4MzUwL3RleHRyZWdpb246MjBkMzhiNjA0MDQyNGRiNGE1ZTQ5ZmQzMGIwYWExNDhfNA_321a4cac-01e9-4e6d-8854-ee2554b18c22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515"
      id="id3VybDovL2RvY3MudjEvZG9jOjRhMWEyYTI1Y2U0YzRiYzVhMjdiMDFiMTRhYjdkZTM2L3NlYzo0YTFhMmEyNWNlNGM0YmM1YTI3YjAxYjE0YWI3ZGUzNl8xL2ZyYWc6NjhkZDc5NmQ4ZTY1NDViOWI5M2UxOTUwNDc2ZDU5ZGUvdGV4dHJlZ2lvbjo2OGRkNzk2ZDhlNjU0NWI5YjkzZTE5NTA0NzZkNTlkZV8yNTA0_e687d4be-178a-47cc-9b39-51ce8e9d3d47">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<F]P<R]A<' N>&UL4$L! A0#%     @ *C*O5C::AX#N    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ *C*O
M5IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    "  J,J]6<MY"Z$$$  !U$   &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ *C*O
M5I^@&_"Q @  X@P   T              ( !A P  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    "  J,J]6EXJ[',     3 @  "P              @ %@#P
M7W)E;',O+G)E;'-02P$"% ,4    "  J,J]6JL0B%C,!   B @  #P
M        @ %)$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ *C*O5B0>
MFZ*M    ^ $  !H              ( !J1$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ *C*O5F60>9(9 0  SP,  !,
M     ( !CA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&V!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="rmti-20230515.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rockwellmed.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="rmti-20230515.htm">rmti-20230515.htm</File>
    <File>rmti-20230515.xsd</File>
    <File>rmti-20230515_lab.xml</File>
    <File>rmti-20230515_pre.xml</File>
    <File>rmtiq12023earningspr-final.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rmti-20230515.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "rmti-20230515.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rmti-20230515_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rmti-20230515_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rmti-20230515.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "rmti",
   "nsuri": "http://rockwellmed.com/20230515",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmti-20230515.htm",
      "contextRef": "ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://rockwellmed.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rmti-20230515.htm",
      "contextRef": "ie6c20d553a3046ddb00e5fe6d898f85f_D20230515-20230515",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-23-017984-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-017984-xbrl.zip
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MQ5SWLKIG:HN8.NKYS /G=OEJ7"-[-2[>R;A2R8GH#/[TTF%P^/]02P,$%
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ME_7YO%U8)VE;85^[[6X%A\NU^=Y;0"?8;/5D\ M02P,$%     @ *C*O5JW
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M&JC,!M,__S@[9U=B04"6+RN2,SW!,GN]K+\\*QBI:LX/XO):1^A/8#,,Z*]
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MEC:, !,>9[X:NAV[O'O449ZOZ^JA??*.:6\=]DL,^V:I,E0[IY0HRG++G<[
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MO#-<.-J[/]%]="_#'^W]#U!+ P04    "  J,J]6SNEO"!H>  #!?@$ '@
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MIWO79L/*@BI\*^[$K2>19HED$"_O9"0&Z?8]@94GK38!:&G.AEHRCBKG,9L
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M=&DM,C R,S U,34N:'1M4$L! A0#%     @ *C*O5A3/W/QK @  :P<  !$
M             ( !Q14  ')M=&DM,C R,S U,34N>'-D4$L! A0#%     @
M*C*O5JW G(YN"@  25X  !4              ( !7Q@  ')M=&DM,C R,S U
M,35?;&%B+GAM;%!+ 0(4 Q0    ( "HRKU9XVP/FLP8  -HP   5
M      "  0 C  !R;71I+3(P,C,P-3$U7W!R92YX;6Q02P$"% ,4    "  J
M,J]6SNEO"!H>  #!?@$ '@              @ 'F*0  <FUT:7$Q,C R,V5A
H<FYI;F=S<'(M9FEN86PN:'1M4$L%!@     %  4 4 $  #Q(      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
